Literature DB >> 16969684

Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.

Nicole I Wolf1, Maria Cundall, Paul Rutland, Elisabeth Rosser, Robert Surtees, Sarah Benton, Wui K Chong, Sue Malcolm, Friedrich Ebinger, Maria Bitner-Glindzicz, Karen J Woodward.   

Abstract

Mutations in GJA12 have been shown to cause Pelizaeus-Merzbacher-like disease (PMLD). We present two additional patients from one family carrying a homozygous frameshift mutation in GJA12. Both presented initially with nystagmus. The older girl developed ataxia first, then progressive spastic ataxia. The younger boy suffered from severe sensory neuropathy. Magnetic resonance imaging (MRI) of both children showed progressive demyelination in addition to dysmyelination, and also characteristic brainstem abnormalities. In children with nystagmus, ataxia and dysmyelination, mutation analysis of GJA12 should be considered early, especially if inheritance is autosomal recessive.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969684     DOI: 10.1007/s10048-006-0062-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  12 in total

1.  Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease.

Authors:  D Ellis; S Malcolm
Journal:  Nat Genet       Date:  1994-04       Impact factor: 38.330

2.  GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.

Authors:  M Bugiani; S Al Shahwan; E Lamantea; A Bizzi; E Bakhsh; I Moroni; M R Balestrini; G Uziel; M Zeviani
Journal:  Neurology       Date:  2006-05-17       Impact factor: 9.910

Review 3.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

4.  Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.

Authors:  B Plecko; S Stöckler-Ipsiroglu; S Gruber; V Mlynarik; E Moser; J Simbrunner; F Ebner; G Bernert; G Harrer; A Gal; D Prayer
Journal:  Neuropediatrics       Date:  2003-06       Impact factor: 1.947

5.  Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.

Authors:  Birgit Uhlenberg; Markus Schuelke; Franz Rüschendorf; Nico Ruf; Angela M Kaindl; Marco Henneke; Holger Thiele; Gisela Stoltenburg-Didinger; Fuat Aksu; Haluk Topaloğlu; Peter Nürnberg; Christoph Hübner; Bernhard Weschke; Jutta Gärtner
Journal:  Am J Hum Genet       Date:  2004-06-10       Impact factor: 11.025

6.  A PLP splicing abnormality is associated with an unusual presentation of PMD.

Authors:  Grace M Hobson; Zhong Huang; Karen Sperle; Deborah L Stabley; Harold G Marks; Franca Cambi
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

7.  Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.

Authors:  N I Wolf; M A A P Willemsen; U F Engelke; M S van der Knaap; P J W Pouwels; I Harting; J Zschocke; E A Sistermans; D Rating; R A Wevers
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

8.  The reflection of histology in MR imaging of Pelizaeus-Merzbacher disease.

Authors:  M S van der Knaap; J Valk
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jan-Feb       Impact factor: 3.825

9.  Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.

Authors:  K Woodward; E Kendall; D Vetrie; S Malcolm
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

10.  Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS.

Authors:  Benjamin Odermatt; Kerstin Wellershaus; Anke Wallraff; Gerald Seifert; Joachim Degen; Carsten Euwens; Babette Fuss; Heinrich Büssow; Karl Schilling; Christian Steinhäuser; Klaus Willecke
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

View more
  12 in total

1.  High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

Authors:  B Bilir; Z Yapici; C Yalcinkaya; I Baris; C M B Carvalho; M Bartnik; B Ozes; M Eraksoy; J R Lupski; E Battaloglu
Journal:  Clin Genet       Date:  2012-02-20       Impact factor: 4.438

2.  "Pelizaeus-Merzbacher-like disease" presenting as complicated hereditary spastic paraplegia.

Authors:  S Zittel; M Nickel; N I Wolf; G Uyanik; D Gläser; C Ganos; C Gerloff; A Münchau; A Kohlschütter
Journal:  J Neurol       Date:  2012-07-26       Impact factor: 4.849

3.  Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction.

Authors:  Simone Diekmann; Marco Henneke; Birgitta C Burckhardt; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

5.  Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.

Authors:  Elena Georgiou; Kyriaki Sidiropoulou; Jan Richter; Christos Papaneophytou; Irene Sargiannidou; Alexia Kagiava; Georg von Jonquieres; Christina Christodoulou; Matthias Klugmann; Kleopas A Kleopa
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 6.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

7.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

8.  Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

Authors:  David N Finegold; Catherine J Baty; Kelly Z Knickelbein; Shelley Perschke; Sarah E Noon; Diana Campbell; Jenny M Karlsson; Diana Huang; Mark A Kimak; Elizabeth C Lawrence; Eleanor Feingold; Stephen D Meriney; Adam M Brufsky; Robert E Ferrell
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

9.  Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.

Authors:  Jennifer L Orthmann-Murphy; Ettore Salsano; Charles K Abrams; Alberto Bizzi; Graziella Uziel; Mona M Freidin; Eleonora Lamantea; Massimo Zeviani; Steven S Scherer; Davide Pareyson
Journal:  Brain       Date:  2008-12-04       Impact factor: 13.501

10.  Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form.

Authors:  Roberta Biancheri; Camillo Rosano; Laura Denegri; Eleonora Lamantea; Francesca Pinto; Federica Lanza; Mariasavina Severino; Mirella Filocamo
Journal:  Eur J Hum Genet       Date:  2012-06-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.